Typ-1-Diabetes Merkmale unter dem Mikroskop

Typ-1-Diabetes (T1D) wird als Folge einer Autoimmunreaktion verstanden, die sich gegen die insulinproduzierenden Betazellen richtet. Diese befinden sich in den Langerhans-Inseln im Pankreas. Die Erkrankung wurde lange Zeit als eine im Kindesalter beginnende Erkrankung betrachtet, die eine lebenslange Insulinbehandlung erfordert. Neuere Studien zeigen jedoch, dass ein Krankheitsbeginn im Erwachsenenalter ebenso häufig ist wie im Kindesalter [1]. Weltweit wird ein Anstieg der Inzidenz um mindestens 66% zwischen den Jahren 2020 und 2040 erwartet. Zudem sind geschätzt 63–70% der Todesfälle bei Personen unter 25 Jahren mit TD 1 auf eine fehlende Diagnose zurückzuführen [2].

Publication History

Article published online:
17 December 2025

• Literatur

• 1 Leslie RD, Evans-Molina C, Freund-Brown J. et al. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care 2021; 44 (11) 2449-2456
• 2 Gregory GA, Robinson TIG, Linklater SE. et al. Global Incidence, Prevalence, and Mortality of Type 1 Diabetes in 2021 with Projection to 2040: A Modelling Study. Lancet Diabetes Endocrinol 2022; 10 (10) 741-760
• 3 Campbell-Thompson M, Fu A, Kaddis JS. et al. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes. Diabetes 2016; 65 (03) 719-731
• 4 Vanderniet JA, Jenkins AJ, Donaghue KC. Epidemiology of Type 1 Diabetes. Curr. Cardiol. Rep 2022; 24 (10) 1455-1465
• 5 Ziegler AG, Rewers M, Simell O. et al. Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children. JAMA 2013; 309 (23) 2473-2479
• 6 Insel RA, Dunne JL, Atkinson MA. et al. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015; 38 (10) 1964-1974
• 7 Pugliese A. Insulitis in the Pathogenesis of Type 1 Diabetes. Pediatr Diabetes 2016; 17 (Suppl. 22) 31-36
• 8 Krogvold L, Wiberg A, Edwin B. et al. Insulitis and Characterisation of Infiltrating T Cells in Surgical Pancreatic Tail Resections from Patients at Onset of Type 1 Diabetes. Diabetologia 2016; 59 (03) 492-501
• 9 Rodriguez-Calvo T, Ekwall O, Amirian N. et al. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014; 63 (11) 3880-3890
• 10 Apaolaza PS, Balcacean D, Zapardiel-Gonzalo J. et al. The Extent and Magnitude of Islet T Cell Infiltration as Powerful Tools to Define the Progression to Type 1 Diabetes. Diabetologia 2023; 66: 1129-1141
• 11 Scherm MG, Wyatt RC, Serr I. et al. Beta Cell and Immune Cell Interactions in Autoimmune Type 1 Diabetes: How They Meet and Talk to Each Other. Mol Metab 2022; 64: 101565
• 12 Sims EK, Bundy BN, Stier K. et al. Type 1 Diabetes TrialNet Study Group. Teplizumab Improves and Stabilizes Beta Cell Function in Antibody-Positive High-Risk Individuals. Sci Transl Med 2021; 13 (583) eabc8980
• 13 Rodriguez-Calvo T, Chen YC, Verchere CB. et al. Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes. Diabetes 2021; 70 (05) 1038-1050
• 14 Hartling SG, Knip M, Røder ME. et al. Longitudinal Study of Fasting Proinsulin in 148 Siblings of Patients with Insulin-Dependent Diabetes Mellitus. Study Group on Childhood Diabetes in Finland. Eur J Endocrinol 1997; 137 (05) 490-494
• 15 Sims EK, Evans-Molina C, Tersey SA. et al. Biomarkers of Islet Beta Cell Stress and Death in Type 1 Diabetes. Diabetologia 2018; 61 (11) 2259-2265
• 16 Tersey SA, Nishiki Y, Templin AT. et al. Islet β-Cell Endoplasmic Reticulum Stress Precedes the Onset of Type 1 Diabetes in the Nonobese Diabetic Mouse Model. Diabetes 2012; 61 (04) 818-827
• 17 Kahn SE, Halban PA. Release of Incompletely Processed Proinsulin Is the Cause of the Disproportionate Proinsulinemia of NIDDM. Diabetes 1997; 46 (11) 1725-1732
• 18 Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N. et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017; 66 (05) 1334-1345
• 19 Sims EK, Chaudhry Z, Watkins R. et al. Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes. Diabetes Care 2016; 39 (09) 1519-1526
• 20 Truyen I, De Pauw P, Jørgensen PN. et al. Proinsulin Levels and the Proinsulin:C-Peptide Ratio Complement Autoantibody Measurement for Predicting Type 1 Diabetes. Diabetologia 2005; 48 (11) 2322-2329
• 21 Van Dalem A, Demeester S, Balti EV. et al. Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio. PloS One 2016; 11 (12) e0166702
• 22 Truyen I, De Grijse J, Weets I. et al. Identification of Prediabetes in First-Degree Relatives at Intermediate Risk of Type I Diabetes. Clin Exp Immunol 2007; 149 (02) 243-250
• 23 Røder ME, Knip M, Hartling SG. et al. Disproportionately Elevated Proinsulin Levels Precede the Onset of Insulin-Dependent Diabetes Mellitus in Siblings with Low First Phase Insulin Responses. The Childhood Diabetes in Finland Study Group. J Clin Endocrinol Metab 1994; 79 (06) 1570-1575
• 24 Triolo TM, Pyle L, Seligova S. et al. Proinsulin:C-Peptide Ratio Trajectories over Time in Relatives at Increased Risk of Progression to Type 1 Diabetes. J Transl Autoimmun 2021; 4: 100089
• 25 Watkins RA, Evans-Molina C, Terrell JK. et al. Proinsulin and Heat Shock Protein 90 as Biomarkers of Beta-Cell Stress in the Early Period after Onset of Type 1 Diabetes. Transl Res J Lab Clin Med 2016; 168: 96-106.e1
• 26 Snorgaard O, Hartling SG, Binder C. Proinsulin and C-Peptide at Onset and during 12 Months Cyclosporin Treatment of Type 1 (Insulin-Dependent) Diabetes Mellitus. Diabetologia 1990; 33 (01) 36-42
• 27 Wasserfall C, Nick HS, Campbell-Thompson M. et al. Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata. Cell Metab 2017; 26 (03) 568-575.e3
• 28 Sims EK, Syed F, Nyalwidhe J. et al. Abnormalities in Proinsulin Processing in Islets from Individuals with Longstanding T1D. Transl. Res J Lab Clin Med 2019; 213: 90-99
• 29 Apaolaza PS, Chen YC, Grewal K. et al. Quantitative Analysis of Islet Prohormone Convertase 1/3 Expression in Human Pancreas Donors with Diabetes. Diabetologia 2024; 67 (12) 2771-2785